Excaliard, an Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials
10/29/2009 7:29:52 AM
More...
|
Excaliard Contracts BioTox Sciences for Preclinical Research Services
11/6/2008 3:06:26 PM
More...
|
Excaliard Appoints Lincoln Krochmal, MD, President & Chief Executive Officer and Jeffrey Jenson, Head of Clinical Operations
10/10/2008 8:16:40 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases; Excaliard Closes $15.5 Million Series A Financing
11/27/2007 6:47:55 AM
More...
|